Cargando…
Reply to Krupenko et al., Comment on “Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382”
Autores principales: | Lee, Seon-Hyeong, Jeon, Yoon, Kang, Joon-Hee, Jang, Hyonchol, Hong, Kyeong-Man, Hong, Dongwan, Lee, Ho, Kim, Soo-Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124425/ https://www.ncbi.nlm.nih.gov/pubmed/34066916 http://dx.doi.org/10.3390/cancers13092238 |
Ejemplares similares
-
Is ALDH1L1 Elevated in Lung Cancer? Comment on: Lee, S.-H.; et al. “The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer” Cancers 2020, 12, 1382
por: Krupenko, Sergey A., et al.
Publicado: (2021) -
The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer
por: Lee, Seon-Hyeong, et al.
Publicado: (2020) -
Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
por: Kesić, Vesna, et al.
Publicado: (2022) -
Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
por: Ramai, Daryl, et al.
Publicado: (2023) -
Response to Letter to Editor by Dr. Aminnejad et al.
por: Shahrokhirad, Reyhaneh, et al.
Publicado: (2019)